Financhill
Buy
53

SEYMF Quote, Financials, Valuation and Earnings

Last price:
$13.08
Seasonality move :
-20.11%
Day range:
$13.08 - $13.08
52-week range:
$11.30 - $18.90
Dividend yield:
0%
P/E ratio:
19.27x
P/S ratio:
8.38x
P/B ratio:
2.53x
Volume:
--
Avg. volume:
--
1-year change:
-30.82%
Market cap:
$1.6B
Revenue:
$207.1M
EPS (TTM):
$0.68
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $38.7M $60.8M $112.5M $146.9M $207.1M
Revenue Growth (YoY) -3.09% 57.32% 84.91% 30.58% 41.01%
 
Cost of Revenues -$3.9M $857.7K $601.1K $403.9K $403.8K
Gross Profit $42.6M $60M $111.9M $146.5M $206.7M
Gross Profit Margin -- 98.59% 99.47% 99.73% 99.81%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $2.9M $2.6M $2.1M $2.4M $3M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $23.7M $22M $25.3M $17.4M $24.2M
Operating Income $18.9M $38M $86.6M $129.1M $182.5M
 
Net Interest Expenses $12M $14.6M $19.8M $22.5M $35.6M
EBT. Incl. Unusual Items $6.5M $23.3M $66.6M $106.6M $146.9M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$20.2M -$11.4M $9.7M $11.6M $30.5M
Net Income to Company $6.5M $23.3M $66.6M $106.6M $146.9M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $26.7M $34.7M $56.8M $95M $116.4M
 
Basic EPS (Cont. Ops) $0.21 $0.27 $0.45 $0.76 $0.93
Diluted EPS (Cont. Ops) $0.21 $0.27 $0.45 $0.76 $0.93
Weighted Average Basic Share $125M $125M $125M $125M $125M
Weighted Average Diluted Share $125M $125M $125M $125M $125M
 
EBITDA $34.3M $54.8M $110.4M $155.5M $217.9M
EBIT $18.3M $37.3M $86.3M $129.1M $183.9M
 
Revenue (Reported) $38.7M $60.8M $112.5M $146.9M $207.1M
Operating Income (Reported) $18.9M $38M $86.6M $129.1M $182.5M
Operating Income (Adjusted) $18.3M $37.3M $86.3M $129.1M $183.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $20.9M $32.8M $40.1M $67.9M $57.3M
Revenue Growth (YoY) 113.04% 57.02% 22.46% 69.26% -15.56%
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $4.5M $6.2M $5.3M $6.9M $18.5M
Operating Income $13M $26.6M $34.9M $61M $38.8M
 
Net Interest Expenses $3.3M $4.5M $4.7M $8.2M $10.2M
EBT. Incl. Unusual Items $9.7M $22.1M $30.1M $52.8M $28.6M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$2.4M $5.7M $4M $13.3M $11.6M
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $12.1M $16.4M $26.2M $39.6M $17M
 
Basic EPS (Cont. Ops) $0.10 $0.13 $0.21 $0.32 $0.14
Diluted EPS (Cont. Ops) $0.10 $0.13 $0.21 $0.32 $0.14
Weighted Average Basic Share $125M $125M $125M $125M $125M
Weighted Average Diluted Share $125M $125M $125M $125M $125M
 
EBITDA $17.6M $32.2M $41.2M $69.3M $51.6M
EBIT $12.8M $26.3M $34.9M $60M $38.5M
 
Revenue (Reported) $20.9M $32.8M $40.1M $67.9M $57.3M
Operating Income (Reported) $13M $26.6M $34.9M $61M $38.8M
Operating Income (Adjusted) $12.8M $26.3M $34.9M $60M $38.5M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $55.9M $99.2M $142.3M $191.5M $194.9M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $27M $22.9M $25M $19.1M $43M
Operating Income $32.6M $75.4M $116.7M $172M $151.4M
 
Net Interest Expenses $14.3M $17.7M $20.3M $32M $40M
EBT. Incl. Unusual Items $17.9M $57.6M $96.2M $140M $111.4M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$21.4M $6.4M $10.3M $25.5M $26.6M
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $39.3M $51.2M $85.9M $114.6M $84.8M
 
Basic EPS (Cont. Ops) $0.31 $0.41 $0.69 $0.92 $0.68
Diluted EPS (Cont. Ops) $0.31 $0.41 $0.69 $0.92 $0.68
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $50.5M $96M $142.3M $206M $194.6M
EBIT $32M $74.7M $116.5M $172.1M $152.8M
 
Revenue (Reported) $55.9M $99.2M $142.3M $191.5M $194.9M
Operating Income (Reported) $32.6M $75.4M $116.7M $172M $151.4M
Operating Income (Adjusted) $32M $74.7M $116.5M $172.1M $152.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $46.3M $84.5M $114.5M $159.5M $147M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $16.8M $17.8M $17.6M $19.1M $37.9M
Operating Income $29.4M $66.7M $97M $140.4M $109.1M
 
Net Interest Expenses $10.5M $13.6M $14.2M $23.9M $28.3M
EBT. Incl. Unusual Items $18.9M $53.1M $82.7M $116.4M $80.8M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$9.5M $8.2M $8.8M $22.7M $18.7M
Net Income to Company $9.1M $31M $51.3M $64M $51.9M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $28.4M $44.9M $73.9M $93.8M $62.1M
 
Basic EPS (Cont. Ops) $0.23 $0.36 $0.59 $0.75 $0.50
Diluted EPS (Cont. Ops) $0.23 $0.36 $0.59 $0.75 $0.50
Weighted Average Basic Share $374.9M $374.9M $374.9M $374.9M $374.9M
Weighted Average Diluted Share $374.9M $374.9M $374.9M $374.9M $374.9M
 
EBITDA $42.5M $83.7M $115.6M $166.7M $143.2M
EBIT $29.4M $66.8M $97M $140.4M $109.1M
 
Revenue (Reported) $46.3M $84.5M $114.5M $159.5M $147M
Operating Income (Reported) $29.4M $66.7M $97M $140.4M $109.1M
Operating Income (Adjusted) $29.4M $66.8M $97M $140.4M $109.1M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $118M $79.9M $159.8M $148.3M $72.8M
Short Term Investments $182.6K $328.4K $340.8K $118K $118.3K
Accounts Receivable, Net $16.1M $22.7M $39M $43.6M $64.6M
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets $154.7M $129.9M $213.2M $215.2M $152.9M
 
Property Plant And Equipment $430.9M $610.6M $760.1M $1B $1.4B
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles $27.2M $56.1M $127.1M $111.5M $122.2M
Other Long-Term Assets -- -- -- -- --
Total Assets $672.7M $880M $1.2B $1.5B $1.8B
 
Accounts Payable $54.8M $74.7M $95M $87.8M $31.3M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $1.8M $1.6M $5.3M $4.5M $5.7M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $90.7M $106.3M $196.6M $198.6M $227.4M
 
Long-Term Debt $334.9M $439.5M $541.3M $734.4M $863.5M
Capital Leases -- -- -- -- --
Total Liabilities $456.2M $606.4M $900.6M $1.2B $1.2B
 
Common Stock $1.4M $1.5M $1.4M $1.3M $1.4M
Other Common Equity Adj -- -- -- -- --
Common Equity $216.5M $273.7M $280.1M $368.1M $578M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- $1.5M $1.3M
Total Equity $216.5M $273.7M $280.1M $369.7M $579.4M
 
Total Liabilities and Equity $672.7M $880M $1.2B $1.5B $1.8B
Cash and Short Terms $118.2M $80.2M $160.2M $148.4M $72.9M
Total Debt $362.8M $458.1M $629.7M $833.9M $1B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $104.5M $186.7M $108.8M $87M $99.2M
Short Term Investments $1.3M $1.1M $856.1K $1.3M $7.4M
Accounts Receivable, Net $32M $46.1M $43M $76.3M $71.7M
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets $137.8M $233.9M $152.7M $164.6M $179.3M
 
Property Plant And Equipment $522.9M $754.7M $871M $1.3B $1.6B
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- $111.7M -- $170.4M
Other Long-Term Assets -- -- -- -- --
Total Assets $773.4M $1.2B $1.2B $1.7B $2.1B
 
Accounts Payable $42.6M $144M $97M $52.2M $100.2M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $1.9M $2.3M $4.4M $4.2M $6.7M
Other Current Liabilities $1.4M -- -- -- --
Total Current Liabilities $63.8M $221.5M $158.3M $198.7M $236.1M
 
Long-Term Debt $409.4M $535.3M $589.8M $829.4M $979.7M
Capital Leases -- -- -- -- --
Total Liabilities $516.6M $883M $914.9M $1.2B $1.4B
 
Common Stock $365M $360.6M -- $329.1M $347.3M
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- $1.4M $1.5M $4.4M
Total Equity $256.7M $304.6M $296.8M $479.5M $650.5M
 
Total Liabilities and Equity $773.4M $1.2B $1.2B $1.7B $2.1B
Cash and Short Terms $105.9M $187.8M $109.7M $88.4M $106.6M
Total Debt $426.1M $609.6M $646.7M $971.6M $1.1B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $6.5M $23.3M $66.6M $106.6M $146.9M
Depreciation & Amoritzation $16M $17.6M $24.1M $26.4M $34.1M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$7.3M -$4.3M -$13.5M -$15.2M -$19M
Change in Inventories -- -- -- -- --
Cash From Operations $16.3M $54.3M $111.2M $125.1M $106.2M
 
Capital Expenditures $111.6M $153.4M $231M $349.6M $355.8M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$111.6M -$153.4M -$231M -$349.6M -$355.8M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $147.5M $85M $227.6M $274.1M $234.7M
Long-Term Debt Repaid -$24M -$28M -$23.2M -$47.6M -$58.6M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $123.5M $57M $204.4M $222.1M $170.1M
 
Beginning Cash (CF) $104.1M $135M $96.2M $161.2M $163.1M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $28.2M -$42.1M $84.6M -$2.3M -$79.4M
Ending Cash (CF) $132.3M $92.9M $180.9M $158.9M $83.7M
 
Levered Free Cash Flow -$95.3M -$99.1M -$119.8M -$224.4M -$249.6M
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Net Income to Stockholders $9.1M $31M $51.3M $64M $51.9M
Depreciation & Amoritzation $8.3M $11M $12.1M $17.1M $20.9M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$6.8M -$15.9M -$18.3M -$21.7M -$8.9M
Change in Inventories -- -- -- -- --
Cash From Operations -$23.2M $91.8M $71.2M $23.7M $81.4M
 
Capital Expenditures $30.6M $166.4M $163.6M $203.8M $120.2M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$30.6M -$166.4M -$163.6M -$203.8M -$120.2M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $25.6M $151.2M $91.5M $121.1M $64.9M
Long-Term Debt Repaid -$17.3M -$10.8M -$35.6M -$27.6M -$49.9M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- -$1.1K
Cash From Financing $8.3M $140.3M $55.9M $93.5M $10.6M
 
Beginning Cash (CF) $130.2M $98M $162.8M $164.3M $83.2M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$45.5M $65.8M -$36.6M -$86.6M -$28.2M
Ending Cash (CF) $84.7M $163.8M $126.2M $77.7M $55.1M
 
Levered Free Cash Flow -$53.8M -$74.6M -$92.5M -$180.1M -$38.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures $30.6M $166.4M $163.6M $203.8M $120.2M
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Net Income to Stockholders $9.1M $31M $51.3M $64M $51.9M
Depreciation & Amoritzation $8.3M $11M $12.1M $17.1M $20.9M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$6.8M -$15.9M -$18.3M -$21.7M -$8.9M
Change in Inventories -- -- -- -- --
Cash From Operations -$23.2M $91.8M $71.2M $23.7M $81.4M
 
Capital Expenditures $30.6M $166.4M $163.6M $203.8M $120.2M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$30.6M -$166.4M -$163.6M -$203.8M -$120.2M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $25.6M $151.2M $91.5M $121.1M $64.9M
Long-Term Debt Repaid -$17.3M -$10.8M -$35.6M -$27.6M -$49.9M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- -$1.1K
Cash From Financing $8.3M $140.3M $55.9M $93.5M $10.6M
 
Beginning Cash (CF) $130.2M $98M $162.8M $164.3M $83.2M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$45.5M $65.8M -$36.6M -$86.6M -$28.2M
Ending Cash (CF) $84.7M $163.8M $126.2M $77.7M $55.1M
 
Levered Free Cash Flow -$53.8M -$74.6M -$92.5M -$180.1M -$38.8M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock